Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) Net Long-Term Debt Issued (Repaid) (2010 - 2026)

Updated

Aytu Biopharma (AYTU) recorded Non-Current Debt of $9.1 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 16.5% from $10.9 million a year earlier and down 4.7% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Net Long-Term Debt Issued (Repaid) (2010 - 2026) Analysis & Trends

Starting with fiscal Q1 2021, Aytu Biopharma's Non-Current Debt history includes 23 quarters.

  • Annual Non-Current Debt has a five-year compound annual growth rate of 119.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Non-Current Debt came in at $10.9 million in FY2025 (+0.2%), $10.88 million in FY2024 (-26.1%), $14.71 million in FY2023 (+3.0%) and $14.28 million in FY2022.
  • The fiscal Q4 2026 figure is the lowest quarterly Non-Current Debt since fiscal Q2 2022.
  • On a year-over-year basis, Non-Current Debt rose in four of the last seven quarters, with an average decline of 11.3%.
  • Peak year-over-year performance for Non-Current Debt in the last five years was growth of 32.1% in fiscal Q3 2022, against a decline of 98.7% in fiscal Q2 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $9.55 million (Q3 2026), $10 million (Q2 2026) and $10.45 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -1.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 9.98 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn -464,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -464,000.00
Mar 31, 2026 -464,000.00
Dec 31, 2025 -465,000.00
Sep 30, 2025 -464,000.00
Jun 30, 2025 -464,000.00
Mar 31, 2025 -464,000.00
Dec 31, 2024 -465,000.00
Sep 30, 2024 -464,000.00
Jun 30, 2024 -15.65 Mn
Mar 31, 2024 -25,000.00
Dec 31, 2023 -23,000.00
Sep 30, 2023 -22,000.00
Jun 30, 2023 -23,000.00
Mar 31, 2023 -73,000.00
Dec 31, 2022 26,000.00
Sep 30, 2022 -26,000.00
Jun 30, 2022 -26,000.00
Mar 31, 2022 -300,000.00
Dec 31, 2021 -89.61 Mn
Sep 30, 2021 -25,000.00
API Access

Aytu Biopharma Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEY